Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is seeking a Vice President, Global Scientific Communications to lead the strategic development and execution of global scientific communication activities across its portfolio, including the ATTR franchise and pipeline assets. This executive leader will oversee Medical Communications & Publications, Medical Information & Review, Medical Training, and the office of Grants and Sponsorships, while partnering with cross-functional teams to ensure the timely dissemination of high-quality scientific evidence. The role involves advancing the company's scientific leadership and reputation among healthcare professionals, researchers, and patient communities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alnylam Pharmaceuticals.
Vice President Global Scientific Communications United States
alnylam
Director, Medical Communications
Immatics
Scientific Director Global Medical Affairs Attr United States
alnylam
Director, Scientific Communications
kaileratherapeutics
Director, Scientific Communications
Gilead Sciences
Sr. Director, Publications & Scientific Communications
BridgeBio Pharma